The Relationship of Developing Metabolic Acidosis With Antiepleptic Drugs in Craniotomy Operations
1 other identifier
observational
35
1 country
1
Brief Summary
The relationship of developing metabolic acidosis with antiepleptic drugs in craniotomy operations
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 22, 2023
CompletedFirst Submitted
Initial submission to the registry
June 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedFirst Posted
Study publicly available on registry
July 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2023
CompletedNovember 7, 2023
November 1, 2023
1 month
June 21, 2023
November 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Preoperative Metabolic Acidosis
The base deficit values in the preoperative, intraoperative and postoperative blood gases taken from the patients and the presence and severity of metabolic acidosis were evaluated. Metabolic acidosis severity was defined by base deficit levels: mild from -3 to -5, moderate from -5 to -10, and severe metabolic acidosis below -10.
Baseline
Intraoperative Metabolic Acidosis
The base deficit values in the preoperative, intraoperative and postoperative blood gases taken from the patients and the presence and severity of metabolic acidosis were evaluated. Metabolic acidosis severity was defined by base deficit levels: mild from -3 to -5, moderate from -5 to -10, and severe metabolic acidosis below -10.
during the operation
Postoperative Metabolic Acidosis
The base deficit values in the preoperative, intraoperative and postoperative blood gases taken from the patients and the presence and severity of metabolic acidosis were evaluated. Metabolic acidosis severity was defined by base deficit levels: mild from -3 to -5, moderate from -5 to -10, and severe metabolic acidosis below -10.
Day 1
Study Arms (4)
Group 1
Patients who have used Zonisamide or Topiramate
Group 2
Patients who have used Lacosamide
Group 3
Patients who have used Carbamazepine
Group 4
Patients who have used levetiracetam
Interventions
The base deficit values in the preoperative, intraoperative and postoperative blood gases taken from the patients and the presence and severity of metabolic acidosis were evaluated. Metabolic acidosis severity was defined by base deficit levels: mild from -3 to -5, moderate from -5 to -10, and severe metabolic acidosis below -10.
Eligibility Criteria
Patients who underwent craniotomy and intracranial surgery at Trakya University Medical Faculty Hospital and used antiepileptic drugs were included in the study as a retrospective file review. The files of 35 patients who met the study criteria were reviewed retrospectively.
You may qualify if:
- Patients undergoing intracranial surgery with craniotomy and using antiepileptic drugs
- ASA I-III
- Patients undergoing elective surgery
You may not qualify if:
- Patients with a surgical procedure time of more than 5 hours
- Patients who received more than 2 units of blood transfusion during the operation
- Patients taking other drugs that can cause metabolic acidosis
- Patients with diabetes mellitus, diabetes insipidus, hepatic or renal disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Trakya University
Edirne, Centrum, 22030, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
SEVTAP HEKİMOĞLU ŞAHİN, Professor
Trakya University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of anesthesiology and reanimation, Principal Investigator, Resident Doctor
Study Record Dates
First Submitted
June 21, 2023
First Posted
July 11, 2023
Study Start
May 22, 2023
Primary Completion
June 30, 2023
Study Completion
August 15, 2023
Last Updated
November 7, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share